Status:

NOT_YET_RECRUITING

Study to Evaluate the Diagnostic Performance of of MAGENTIQ-COLO During Colonoscopy.

Lead Sponsor:

Magentiq Eye LTD

Conditions:

Screening Colonoscopy

Surveillance Colonoscopy

Eligibility:

All Genders

45-80 years

Phase:

NA

Brief Summary

This is an international, multicenter, study to evaluate the diagnostic performance of the CADx polyp sizing modality of the MAGENTIQ-COLO.

Detailed Description

Colonoscopy is the gold standard for the detection and removal of premalignant colorectal polyps. Recommended post-polypectomy surveillance intervals are primarily based on pathological diagnosis and ...

Eligibility Criteria

Inclusion

  • Individuals aged ≥45 - ≤80 years old, who are scheduled for non-iFOBT screening or surveillance colonoscopy.

Exclusion

  • In situ polyps with known histology detected in a previous colonoscopy.
  • No colorectal polyps detected during colonoscopy.
  • Known or suspected inflammatory bowel disease.
  • Polyposis syndrome (e.g., familial adenomatous polyposis, serrated polyposis).
  • Non-hereditary polyposis syndromes (e.g. Lynch syndrome).
  • History of chemotherapy or radiation therapy for colorectal lesions.
  • Pregnancy.
  • Has a referral for therapeutic procedure (i.e., endoscopic mucosal resection, intervention to stop a lower gastro-intestinal bleeding, etc.).
  • Inability to undergo polypectomy (e.g., incorrect continued use of anticoagulants, comorbidities) or patient refusal, as assessed by the endoscopist.
  • Inability to provide informed consent.

Key Trial Info

Start Date :

September 15 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

August 31 2025

Estimated Enrollment :

330 Patients enrolled

Trial Details

Trial ID

NCT06568523

Start Date

September 15 2024

End Date

August 31 2025

Last Update

August 23 2024

Active Locations (5)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (5 locations)

1

Johns Hopkins Hospital

Baltimore, Maryland, United States, 21202

2

Erlanger Health System

Chattanooga, Tennessee, United States, 37403

3

Assuta

Haifa, Select State, Israel

4

Hadassah Medical Organization

Jerusalem, Israel, 91120